Form 4: Oscar Health Executive Alessandrea C. Quane Reports Stock Transactions
SEC Form 4
EVP and Chief Insurance Officer of Oscar Health, Alessandrea C. Quane, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.
Summary
- Alessandrea C. Quane, EVP and Chief Insurance Officer at Oscar Health, reported transactions involving Class A Common Stock and Restricted Stock Units.
- On March 5, 2024, 31,250 shares were acquired through the vesting of Restricted Stock Units.
- On March 6, 2024, 13,233 shares were sold at a weighted average price of $14.12 per share, ranging from $13.99 to $14.23.
- Following these transactions, Quane directly owns 212,850 shares of Class A Common Stock and indirectly owns 76,857 shares through a 2024 GRAT.
- Quane also holds 93,750 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a normal part of corporate governance and are publicly disclosed to ensure transparency. These transactions can be influenced by personal financial planning and company performance.
Comparison to Industry Standards
- Executive stock transactions are routinely disclosed across the healthcare industry, with companies like UnitedHealth Group (UNH) and Cigna (CI) also reporting similar Form 4 filings.
- The use of Rule 10b5-1 trading plans is a common practice among executives to avoid accusations of insider trading, aligning with practices seen at companies like Humana (HUM) and Anthem (ANTM).
- The vesting schedules for restricted stock units are typical, often tied to employment tenure and performance metrics, similar to equity compensation plans at Aetna (CVS Health).
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
- The sale of shares to cover tax obligations is a standard practice and should not significantly affect employee morale.
Key Dates
| Date | Description |
|---|---|
| February 27, 2023 | Date prior to which the Rule 10b5-1 instruction letter was entered into. |
| December 5, 2021 | Date when 25% of the Restricted Stock Units vested. |
| March 5, 2024 | Date of acquisition of Class A Common Stock through vesting of Restricted Stock Units. |
| March 6, 2024 | Date of sale of Class A Common Stock. |
| March 7, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.